Utilizing home therapy for cancer-related lymphedema can lower costs

Share this content:
Home Therapy for Cancer-Linked Lymphedema Reduces Costs
Home Therapy for Cancer-Linked Lymphedema Reduces Costs

(HealthDay News) -- Home therapy for cancer-related lymphedema reduces the cost of treating the condition, according to a new study published online Dec. 3 in PLOS ONE.

Researchers examined the home use of pneumatic compression devices to treat lymphedema. The Stanford team focused on pneumatic compression devices because it was the easiest therapy to track using health insurance data, not necessarily because it's the best treatment, they said.

The average annual cost of care for a patient with lymphedema fell from $62,190 to $50,857 when the pneumatic compression devices were used at home. "Total health care costs for these patients are very high, but can be profoundly reduced with treatment intervention, in this case a compression device," senior author Stanley Rockson, M.D., a professor of cardiovascular medicine at Stanford University, said in a university news release.

"Cancer rates are expected to continue increasing at significant rates for the next 20 years. We can expect to see corresponding increasing rates of lymphedema," Rockson said. "The potential public health implications of these findings are substantial. As the American population ages and lymphedema rates increase, effective home therapies are likely to become increasingly important."

Full Text

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs